Signal enhancement ratio (SER) quantified from breast DCE-MRI and breast cancer risk

Shandong Wu; Brenda F. Kurland; Wendie A. Berg M.D.; Margarita L. Zuley M.D.; Rachel C. Jankowitz M.D.; Jules Sumkin; David Gur

doi:10.1117/12.2082466

20 March 2015 Signal enhancement ratio (SER) quantified from breast DCE-MRI and breast cancer risk

Shandong Wu, Brenda F. Kurland, Wendie A. Berg M.D., Margarita L. Zuley M.D., Rachel C. Jankowitz M.D., Jules Sumkin, David Gur

Author Affiliations +

Proceedings Volume 9414, Medical Imaging 2015: Computer-Aided Diagnosis; 94140M (2015) https://doi.org/10.1117/12.2082466
Event: SPIE Medical Imaging, 2015, Orlando, Florida, United States

Abstract

Breast magnetic resonance imaging (MRI) is recommended as an adjunct to mammography for women who are considered at elevated risk of developing breast cancer. As a key component of breast MRI, dynamic contrast-enhanced MRI (DCE-MRI) uses a contrast agent to provide high intensity contrast between breast tissues, making it sensitive to tissue composition and vascularity. Breast DCE-MRI characterizes certain physiologic properties of breast tissue that are potentially related to breast cancer risk. Studies have shown that increased background parenchymal enhancement (BPE), which is the contrast enhancement occurring in normal cancer-unaffected breast tissues in post-contrast sequences, predicts increased breast cancer risk. Signal enhancement ratio (SER) computed from pre-contrast and post-contrast sequences in DCE-MRI measures change in signal intensity due to contrast uptake over time and is a measure of contrast enhancement kinetics. SER quantified in breast tumor has been shown potential as a biomarker for characterizing tumor response to treatments. In this work we investigated the relationship between quantitative measures of SER and breast cancer risk. A pilot retrospective case-control study was performed using a cohort of 102 women, consisting of 51 women who had diagnosed with unilateral breast cancer and 51 matched controls (by age and MRI date) with a unilateral biopsy-proven benign lesion. SER was quantified using fully-automated computerized algorithms and three SER-derived quantitative volume measures were compared between the cancer cases and controls using logistic regression analysis. Our preliminary results showed that SER is associated with breast cancer risk, after adjustment for the Breast Imaging Reporting and Data System (BI-RADS)-based mammographic breast density measures. This pilot study indicated that SER has potential for use as a risk factor for breast cancer risk assessment in women at elevated risk of developing breast cancer.

Citation Download Citation

Shandong Wu, Brenda F. Kurland, Wendie A. Berg M.D., Margarita L. Zuley M.D., Rachel C. Jankowitz M.D., Jules Sumkin, and David Gur "Signal enhancement ratio (SER) quantified from breast DCE-MRI and breast cancer risk", Proc. SPIE 9414, Medical Imaging 2015: Computer-Aided Diagnosis, 94140M (20 March 2015); https://doi.org/10.1117/12.2082466

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available